Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology
PRINCIPAL INVESTIGATORS
- Josep Llop Talaveron
- Pedro Alia Ramos
- Beatriz Candas Estebanez
- Elisabet Leiva Badosa
- Helena Colom Codina
CLINICAL RESEARCHERS
- Eugènia Santacana Juncosa
- Marc Suñé Pou
- Núria Llecha Cano
- Maria Badia Tahull
- Encarna Garcia Montoya
- Montserrat Miñarro Carmona
- Maria Pilar Perez Lozano
- Josep Maria Suñe Negre
- Josep Ramon Tico Grau
- Roser Juvany Roig
- Ariadna Padro Miquel
- Ariadna Padullés Zamora
PREDOCTORAL RESEARCHERS
- Sara Cobo Sacristan
- Ana Suárez-Lledó Grande
- Montserrat Colls Gonzalez
- Lorena Maria Santulario Verdu
- Leticia Garrido Sanchez
- Javier Martínez Casanova
MANAGEMENT SUPPORT
- Ana Maria Ferrer Artola
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
Scientific production
13
PAPERS
Average IF: 4,679
7
LED PAPERS
Average IF: 4,837
4 PUBLICATIONS IN FIRST QUARTILE
9 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Paño Pardo JR, Moreno Rodilla E, Cobo Sacristan S, Cubero Saldaña JL, Periañez Párraga L, Del Pozo León JL, Retamar Genti P, Rodríguez Oviedo A, Torres Jaén MJ, Vidal Cortes P, Colás Sanz C. Management of Patients with Suspected or Confirmed Antibiotic Allergy. Executive Summary of Guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC). J Investig Allergol Clin Immunol. 2022;33(2):doi:10.18176/jiaci.0859.
- Amorós Galicia L, Nardi Ricart A, Verdugo González C, Arroyo García CM, García Montoya E, Pérez Lozano P, Suñé Negre JM, Suñé Pou M. Development of a Standardized Method for Measuring Bioadhesion and Mucoadhesion That Is Applicable to Various Pharmaceutical Dosage Forms. Pharmaceutics. 2022;14(10):doi:10.3390/pharmaceutics14101995.
- Ronda M, Pérez Recio S, González Laguna M, Tubau Quintano MF, Llop Talaveron J, Soldevila Boixader L, Carratalà J, Cuervo G, Padullés A. Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience. J Clin Pharm Ther. 2022;47(7):932-939. doi:10.1111/jcpt.13623.
- Romero Pinel L, Bau L, Matas E, León I, Juvany R, Jódar R, Martínez Yélamos A, Martínez Yélamos S. Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator. PLoS One. 2022;17(4):267504-267504. doi:10.1371/journal.pone.0267504.
- Llop Talaveron J, Leiva Badosa E, Alia Ramos P, Rigo Bonnin R, Virgili Casas N, Farran Teixidor L, Miró Martín M, Garrido Sanchez L, Suárez Lledó A, Badía Tahull MB. Genetic factors associated with alterations in liver function test results in adult hospitalized patients treated with parenteral nutrition: A substudy of a clinical trial. Nutrition. 2022;93111507-111507. doi:10.1016/j.nut.2021.111507.
Research highlights
PROJECTS
4 Ongoing competitive projects
2 started clinical trials
4 Ongoing clinical trials
PUBLISHED WORKS
2 Clinical guidelines
NETWORKS
AGAUR SGR
Selected projects
- 21MAR009. Catalan interhospital network of genetic variants to improve genetic diagnosis in rare diaseases. (202040-32) . FUNDACIÓ LA MARATÓ DE TV3. Budget: 26.625,00. 2021-2024. PI: PADRO MIQUEL, ARIADNA.
- FIS21079. Aplicación de los modelos de cinética poblacional de tacrolimus en distintas poblaciones de trasplante. Papel de los polimorfismos del CYP3A en el trasplante de renal y trasplante hepático (adulto y pediátrico). INSTITUTO DE SALUD CARLOS III (ISCIII). Budget: 200206,6. 2022-2024. PI: COLOM CODINA, HELENA i LLOBERAS BLANC, NURIA.
- 19INT001. Antibiotic plasma level concentrations during continuous renal replacement therapy with a high absorptive membrane (oXiris®). BAXTER HEALTHCARE CORPORATION. Budget: 11.065,26. 2019-2023. PI: COLOM CODINA, HELENA.
- 19FIS011. Mecanismos post-transcripcionales reguladores de la respuesta inflamatoria en aterosclerosis y Enfermedad Renal Crónica: Tráfico de macrófagos, polarización, formación de células espumosa (PI18/01108) . INSTITUTO DE SALUD CARLOS III (ISCIII). Budget: 220.220,00. 2019-2022. PI: SUÑE NEGRE, JOSEP MARIA.
- FAR-NP-2017-01 AC012/17. ENSAYO CLÍNICO PILOTO, RANDOMIZADO, DOBLE CIEGO, PARA ESTUDIAR EL EFECTO DE LA SUPLEMENTACIÓN PARENTERAL CON EMULSIÓN DE ACEITE DE PESCADO EN EL SOPORTE NUTRICIONAL EN PACIENTES ESOFAGECTOMIZADOS. BADIA TAHULL, MARIA BELLA. Budget: 0. 2018-2022. PI: BADIA TAHULL, MARIA BELLA.
.